Status:
COMPLETED
Clotting Genetic Variants, Hormones, and Venous Thrombosis
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Thromboembolism
Eligibility:
FEMALE
18-89 years
Brief Summary
To identify genetic variants in 12 key blood clotting proteins that may modify the risk of venous thromboembolism in users of hormone replacement therapy.
Detailed Description
BACKGROUND: Venous thromboembolism (VTE) occurs commonly in adults and risk increases 3-fold among users of hormone replacement therapy (HRT), oral contraceptives (OC), and selective estrogen recepto...
Eligibility Criteria
Inclusion
- No eligibility criteria
Exclusion
Key Trial Info
Start Date :
May 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00094185
Start Date
May 1 2004
End Date
March 1 2009
Last Update
December 20 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.